Based on functional characterization results, we classified the 25 B-ALL-related NBN variants as “pathogenic”, “likely pathogenic” and “likely benign”, as summarized in Table 2. This evidence concerns the gene NBN and precursor B-cell acute lymphoblastic leukemia.